• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食欲不振与肌萎缩侧索硬化症患者的体重和体脂减少有关。

Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis.

机构信息

Australian Institute for Bioengineering and Nanotechnology, The University of Queensland , Brisbane , Australia.

Queensland Brain Institute, The University of Queensland , Brisbane , Australia.

出版信息

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):497-505. doi: 10.1080/21678421.2019.1621346. Epub 2019 May 30.

DOI:10.1080/21678421.2019.1621346
PMID:31144522
Abstract

: Weight loss in amyotrophic lateral sclerosis (ALS) is associated with faster disease progression and shorter survival. It has different possible causes, including loss of appetite. Our objective is to determine the prevalence and impact of loss of appetite on change in body weight and composition in patients with ALS. : We conducted a prospective case-control study, comparing demographic, clinical, appetite and prognostic features between 62 patients with ALS and 45 healthy non-neurodegenerative disease (NND) controls. To determine the impact of loss of appetite on weight throughout disease course, we conducted serial assessments at ∼three to four-month intervals. : Loss of appetite is more prevalent in patients with ALS than NND controls (29 vs. 11.1%, odds ratio = 3.27 (1.1-9.6);  < 0.01). In patients with ALS, loss of appetite is associated with greater weight loss and greater loss of fat mass. Appetite scores in patients with ALS worsens as disease progresses and are correlated with worsening ALS Functional Rating Scale-Revised scores. : We confirm that loss of appetite is prevalent in patients with ALS and is significantly associated with weight loss and loss of fat mass. Appetite worsens with disease progression. Identification and early interventions to address loss of appetite in patients with ALS may prevent or slow weight loss; this could improve disease outcome.

摘要

肌萎缩侧索硬化症(ALS)患者的体重减轻与疾病进展更快和生存期更短有关。其可能有不同的原因,包括食欲下降。我们的目的是确定食欲下降对 ALS 患者体重和身体成分变化的影响。

我们进行了一项前瞻性病例对照研究,比较了 62 名 ALS 患者和 45 名健康非神经退行性疾病(NND)对照组的人口统计学、临床、食欲和预后特征。为了确定食欲下降对疾病过程中体重的影响,我们在大约每三到四个月进行一次连续评估。

食欲下降在 ALS 患者中比 NND 对照组更为常见(29%比 11.1%,比值比=3.27(1.1-9.6);<0.01)。在 ALS 患者中,食欲下降与体重下降和脂肪量减少更多有关。ALS 患者的食欲评分随着疾病的进展而恶化,并且与 ALS 功能评定量表修订版评分的恶化相关。

我们证实,食欲下降在 ALS 患者中很常见,与体重减轻和脂肪量减少显著相关。随着疾病的进展,食欲恶化。在 ALS 患者中识别和早期干预食欲下降可能预防或减缓体重减轻,这可能改善疾病结局。

相似文献

1
Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis.食欲不振与肌萎缩侧索硬化症患者的体重和体脂减少有关。
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):497-505. doi: 10.1080/21678421.2019.1621346. Epub 2019 May 30.
2
Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis.下丘脑海体量随着体重指数降低与肌萎缩侧索硬化患者的生存时间更短相关。
Eur J Neurol. 2023 Jan;30(1):57-68. doi: 10.1111/ene.15589. Epub 2022 Nov 8.
3
Associations of postprandial ghrelin, liver-expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis.餐后胃饥饿素、肝表达抗菌肽 2 和瘦素水平与肌萎缩侧索硬化症患者的身体成分、疾病进展和生存的关系。
Eur J Neurol. 2024 Jan;31(1):e16052. doi: 10.1111/ene.16052. Epub 2023 Sep 1.
4
Loss of appetite in patients with amyotrophic lateral sclerosis is associated with weight loss and anxiety/depression.肌萎缩侧索硬化症患者的食欲不振与体重减轻和焦虑/抑郁有关。
Sci Rep. 2021 Apr 27;11(1):9119. doi: 10.1038/s41598-021-88755-x.
5
Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study.脂肪量减少与肌萎缩侧索硬化症患者疾病进展更快相关:在一项前瞻性研究中探索双能 X 射线吸收法的实用性。
PLoS One. 2021 May 6;16(5):e0251087. doi: 10.1371/journal.pone.0251087. eCollection 2021.
6
Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia.生命历程体重指数与肌萎缩侧索硬化症的风险和预后:来自 ALS 登记处 Swabia 的结果。
Eur J Epidemiol. 2017 Oct;32(10):901-908. doi: 10.1007/s10654-017-0318-z. Epub 2017 Oct 3.
7
Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.体重和用力肺活量进展率作为相关指标,以调整肌萎缩侧索硬化症的管理以适应患者结果:一项法国多中心队列研究。
J Neurol Sci. 2013 Aug 15;331(1-2):126-31. doi: 10.1016/j.jns.2013.06.002. Epub 2013 Jun 25.
8
Loss of appetite in amyotrophic lateral sclerosis is associated with weight loss and decreased calorie consumption independent of dysphagia.肌萎缩侧索硬化症患者的食欲不振与体重减轻和热量摄入减少有关,与吞咽困难无关。
Muscle Nerve. 2020 Feb;61(2):230-234. doi: 10.1002/mus.26749. Epub 2019 Nov 18.
9
Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study.诊断后体重变化对 ALS 预后的意义:一项单中心前瞻性队列研究。
J Neurol. 2019 Jun;266(6):1412-1420. doi: 10.1007/s00415-019-09276-2. Epub 2019 Mar 13.
10
Hypermetabolism in ALS is associated with greater functional decline and shorter survival.肌萎缩侧索硬化症中的代谢亢进与更大的功能下降和更短的生存时间相关。
J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1016-1023. doi: 10.1136/jnnp-2017-317887. Epub 2018 Apr 29.

引用本文的文献

1
Regulation of synaptic function and lipid metabolism.突触功能与脂质代谢的调节。
Neural Regen Res. 2026 Mar 1;21(3):1037-1057. doi: 10.4103/NRR.NRR-D-24-01412. Epub 2025 Apr 29.
2
Appetite loss in patients with motor neuron disease: impact on weight loss and neural correlates of visual food cues.运动神经元病患者的食欲减退:对体重减轻的影响及视觉食物线索的神经关联
Brain Commun. 2025 Mar 14;7(2):fcaf111. doi: 10.1093/braincomms/fcaf111. eCollection 2025.
3
An fMRI dataset for appetite neural correlates in people living with Motor Neuron Disease.
一项针对运动神经元病患者食欲神经关联的功能磁共振成像数据集。
Sci Data. 2025 Mar 20;12(1):466. doi: 10.1038/s41597-025-04828-w.
4
Nutritional and Microbiota-Based Approaches in Amyotrophic Lateral Sclerosis: From Prevention to Treatment.肌萎缩侧索硬化症中基于营养和微生物群的方法:从预防到治疗
Nutrients. 2024 Dec 30;17(1):102. doi: 10.3390/nu17010102.
5
A single-center, single-arm, prospective, open-label, and comparative trial to evaluate the safety and tolerability profile of a 90-day oral L-arginine hydrochloride intervention for patients with amyotrophic lateral sclerosis.一项单中心、单臂、前瞻性、开放标签的对照试验,旨在评估为期90天的口服盐酸L-精氨酸干预对肌萎缩侧索硬化症患者的安全性和耐受性。
Sci Rep. 2025 Jan 7;15(1):1120. doi: 10.1038/s41598-024-84944-6.
6
Association Between Early-Life and Premorbid Measurements of Body Composition and Risk of Motor Neuron Disease: A Prospective Cohort Study in the UK Biobank.早年身体成分测量和病前测量与运动神经元病风险之间的关联:英国生物银行的一项前瞻性队列研究
Ann Neurol. 2025 Feb;97(2):259-269. doi: 10.1002/ana.27109. Epub 2024 Oct 25.
7
Mapping the Evidence for Measuring Energy Expenditure and Indicating Hypermetabolism in Motor Neuron Disease: A Scoping Review.绘制运动神经元病中测量能量消耗和指示高代谢的证据图谱:一项范围综述
Nutr Rev. 2025 May 1;83(5):943-960. doi: 10.1093/nutrit/nuae118.
8
Sensory Changes Related to Swallowing in Motor Neurone Disease.运动神经元病中与吞咽相关的感觉变化
Dysphagia. 2025 Apr;40(2):407-418. doi: 10.1007/s00455-024-10742-x. Epub 2024 Aug 3.
9
Internal Psychometric Validation of an International Burden of Illness Survey for Idiopathic Multicentric Castleman Disease.特发性多中心Castleman病国际疾病负担调查的内部心理测量学验证
Oncol Ther. 2024 Sep;12(3):491-508. doi: 10.1007/s40487-024-00293-4. Epub 2024 Jul 16.
10
Non-motor symptoms in patients with amyotrophic lateral sclerosis: current state and future directions.肌萎缩侧索硬化症患者的非运动症状:现状与未来方向。
J Neurol. 2024 Jul;271(7):3953-3977. doi: 10.1007/s00415-024-12455-5. Epub 2024 May 28.